Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study

NCT03082274 is registered in ClinicalTrials.gov with MDx Health as lead sponsor.

NCT NCT03082274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03082274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study
Lead sponsor
MDx Health
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2017
Completion date
December 30, 2019
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer